About Education & Research at Perlmutter Cancer Center

About Education & Research at Perlmutter Cancer Center

We develop life-changing cancer treatments and train future oncologists.
Dr. Eva M. Hernando-Monge with a Group of Medical Students

Benjamin G. Neel, MD, PhD

Director, Laura and Isaac Perlmutter Cancer Center

At NYU Langone Health’s Perlmutter Cancer Center, we are dedicated to advancing cancer research and education to develop innovative, life-changing new treatments for people with cancer while training the next generation of oncologists. Our multidisciplinary teams of scientists and clinicians collaborate to investigate diagnostic methods and novel therapies, leading to advances in treatments—such as immunotherapy and targeted biological agents—for a wide range of cancers. 

Our robust phase I clinical trials program gives patients unprecedented access to novel treatment options, should their first line of therapy fail. Our faculty has shown national leadership in early-phase and investigator-initiated trials, offering a diverse clinical trial portfolio and pioneering advancements in the application of immunotherapy to cancer. 

Our reputation as leaders in cancer research and education continues to attract high-profile recruits, including world-renowned physician-scientists and clinical trial specialists, to our faculty. As a result, our colleagues continue to make significant contributions, from leading cutting-edge clinical trials to faculty and research team collaborations.

With several new locations and a growing roster of physicians, Perlmutter Cancer Center is delivering world-class care to more patients than ever at more than 20 locations across Manhattan, Brooklyn, Queens, and Long Island. Our expanded footprint allows us to serve one of the largest, most diverse patient bases in the nation. With pioneering research, exceptional medical education, and innovative clinical trials, we continue to shape the future of cancer care.

Contact Us

For more information about education and research at Perlmutter Cancer Center, please contact us at 212-263-3276.

Our Senior Leadership

Tim Strawderman photo

Tim Strawderman, PhD

Executive Director for Administration

Jiyoung Ahn, PhD

Associate Director, Population Sciences

Abraham Chachoua, MD

Associate Director, Cancer Services

Francisco J. Esteva, MD, PhD

Associate Director, Clinical Research

Eva M. Hernando-Monge, PhD

Associate Director, Basic Research

Mark R. Philips, MD

Associate Director, Education and Training

Chau Trinh-Shevrin, DrPH

Associate Director, Community Outreach and Engagement

Diane M. Simeone, MD

Associate Director, Translational Research

General Administration

Thomas Walsh, Director for Business and Finance

Laura Alice, Associate Director for Grants and Research Administration

Danielle Iavarone, Assistant Director, Community Outreach and Education

Clinical and Patient Care Administration

Kevin Kirchen, Vice President of Operations, NYU Langone Health

Abraham Chachoua, MD, Associate Director of Cancer Services, Medical Director

Michael J. Zeller, Senior Administrative Director, Operations, Business, and Finance

James Loos, Senior Administrative Director, Operations, Business and Finance

Joan Scagliola, RN, Senior Director of Nursing, Ambulatory Oncology

Clinical Trials Office

Erica Love, Administrative Director

Division of Hematology and Medical Oncology

Kasey Bond, Division Administrator

Office of Communications and Marketing

Jim Mandler, Senior Director for Media Relations—Health, Clinical, and Research
jim.mandler@nyumc.org
212-404-3535

Jeffrey Molter, Director of Communications, Perlmutter Cancer Center
jeffrey.molter@nyumc.org
212-263-9423
Please contact for corporate and internal communications inquiries, as well as inquiries about pancreatic cancer.

Catherine G. Fontana, Senior Marketing Manager